Skip to main content
. Author manuscript; available in PMC: 2023 Feb 7.
Published in final edited form as: Chem Soc Rev. 2022 Feb 7;51(3):829–868. doi: 10.1039/d0cs00771d

Figure 3.

Figure 3.

a) Schematic of B7-H3-ICG. b) PA images of normal mice before and after injection of B7-H3-ICG (first column) and breast cancer-bearing mice before and after injection with B7-H3-ICG, iso-ICG or B7-H3-ICG with blocking. c) Schematic of ABYB7-H3-ICG. d) PA images of normal glands before and after administration of ABYB7-H3-ICG (first column) and mammary tumors before and after administration of ABYB7-H3-ICG, ABYB7-H3-ICG with blocking, and ABYSCR-ICG scrambled control. a) and b) are reproduced from ref. 42, which is an open-access article distributed under the Creative Commons Attribution (CC BY-NC) License, 2017 Ivyspring International Publisher. c) and d) are reproduced from ref. 44 with permission from American Chemical Society, Copyright 2019.